j.neo.2016.02.005

C1qTNF5/CTRP5 Antibody (332923) [Alexa Fluor® 750] Summary

    Immunogen
    Mouse myeloma cell line NS0-derived recombinant human C1qTNF5
    Ser16-Ala243 (Gln44Arg)
    Accession # Q9BXJ0
    Specificity
    Detects human C1qTNF5 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) C1qTNF1 or rhC1qTNF4 is observed.
    Isotype
    IgG2b
    Clonality
    Monoclonal
    Host
    Mouse
    Innovators Reward
    Test in a species/application not listed above to receive a full credit towards a future purchase.

    Learn about the Innovators Reward

Applications/Dilutions

    Dilutions
        Intracellular Staining by Flow Cytometry 0.25-1 ug/10^6 cells

Packaging, Storage & Formulations

    Storage
    Store the unopened product at 2 – 8 °C. Do not use past expiration date.
    Buffer
    Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for C1qTNF5/CTRP5 Antibody (332923) [Alexa Fluor® 750]

      C1q and tumor necrosis factor related protein 5
      C1qTNF5
      Complement C1q Tumor Necrosis Factor-Related Protein 5 Precursor Variant 3
      CTRP5
      CTRP5LORDDKFZp586B0621
      LORD 6
      Myonectin 3

Background

C1qTNF5, also known as CTRP5, belongs to the highly conserved family of Acrp30/Adiponectin paralogs known as C1q and TNF‑related protein family. All family members share a modular organization comprising an N‑terminal signal peptide, a short variable region, a collagenous domain and a C‑terminal globular domain. C1qTNF proteins are predicted to have trimeric structures that assemble into hexameric and higher order molecular forms. Human and mouse C1qTNF5 share 94% amino acid sequence identity.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

product targets : IAP inhibitors

Related Post